Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30652
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSapir, Tamar-
dc.contributor.authorKshirsagar, Aditya-
dc.contributor.authorGorelik, Anna-
dc.contributor.authorOlender, Tsviya-
dc.contributor.authorPorat, Ziv-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorGoldstein, David B-
dc.contributor.authorDevinsky, Orrin-
dc.contributor.authorReiner, Orly-
dc.date2022-
dc.date.accessioned2022-08-02T06:42:50Z-
dc.date.available2022-08-02T06:42:50Z-
dc.date.issued2022-07-21-
dc.identifier.citationNature communications 2022; 13(1): 4209en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30652-
dc.description.abstractHNRNPU encodes the heterogeneous nuclear ribonucleoprotein U, which participates in RNA splicing and chromatin organization. Microdeletions in the 1q44 locus encompassing HNRNPU and other genes and point mutations in HNRNPU cause brain disorders, including early-onset seizures and severe intellectual disability. We aimed to understand HNRNPU's roles in the developing brain. Our work revealed that HNRNPU loss of function leads to rapid cell death of both postmitotic neurons and neural progenitors, with an apparent higher sensitivity of the latter. Further, expression and alternative splicing of multiple genes involved in cell survival, cell motility, and synapse formation are affected following Hnrnpu's conditional truncation. Finally, we identified pharmaceutical and genetic agents that can partially reverse the loss of cortical structures in Hnrnpu mutated embryonic brains, ameliorate radial neuronal migration defects and rescue cultured neural progenitors' cell death.en
dc.language.isoeng
dc.titleHeterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex.en
dc.typeJournal Articleen
dc.identifier.journaltitleNature communicationsen
dc.identifier.affiliationThe University of Melbourne, Royal Children's Hospital, and Murdoch Children's Research Institutes, Melbourne, VIC, Australia..en
dc.identifier.affiliationDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel..en
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationFlow Cytometry Unit, Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel..en
dc.identifier.affiliationInstitute for Genomic Medicine, Columbia University, New York, NY, USA..en
dc.identifier.affiliationNYU Langone Medical Center, NYU, New York, NY, USA..en
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35864088/en
dc.identifier.doi10.1038/s41467-022-31752-zen
dc.type.contentTexten
dc.identifier.orcidhttp://orcid.org/0000-0001-8926-9353en
dc.identifier.orcidhttp://orcid.org/0000-0003-3059-181Xen
dc.identifier.orcidhttp://orcid.org/0000-0002-2311-2174en
dc.identifier.orcidhttp://orcid.org/0000-0003-0044-4632en
dc.identifier.orcidhttp://orcid.org/0000-0001-7560-9599en
dc.identifier.pubmedid35864088
local.name.researcherScheffer, Ingrid E
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Nov 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.